Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Haastrup E, Fischer-Nielsen A, Reekie J, Sengelov H. Minculescu L, et al. Among authors: friis ls. Front Immunol. 2019 Aug 22;10:1997. doi: 10.3389/fimmu.2019.01997. eCollection 2019. Front Immunol. 2019. PMID: 31507601 Free PMC article.
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes.
Wedge E, Sengeløv H, Hansen JW, Andersen NS, Schjødt I, Petersen SL, Kornblit B, Grønbæk K, Friis LS. Wedge E, et al. Among authors: friis ls. Biol Blood Marrow Transplant. 2020 Jun;26(6):1091-1098. doi: 10.1016/j.bbmt.2020.02.010. Epub 2020 Feb 20. Biol Blood Marrow Transplant. 2020. PMID: 32088368 Free article.
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.
Minculescu L, Fischer-Nielsen A, Haastrup E, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Sengelov H, Marquart HV. Minculescu L, et al. Among authors: friis ls. Front Immunol. 2020 May 29;11:1068. doi: 10.3389/fimmu.2020.01068. eCollection 2020. Front Immunol. 2020. PMID: 32547559 Free PMC article.
Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre- and post-transplantation cytokine responses in stimulated whole blood.
Gjaerde LK, Brooks PT, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Nielsen SD, Ostrowski SR, Sengeløv H. Gjaerde LK, et al. Among authors: friis ls. Scand J Immunol. 2021 Jul;94(1):e13042. doi: 10.1111/sji.13042. Epub 2021 Apr 12. Scand J Immunol. 2021. PMID: 33772836 Free article.
Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study.
Gjærde LK, Rank CU, Andersen MK, Jakobsen LH, Sengeløv H, Olesen G, Kornblit B, Marquart H, Friis LS, Petersen SL, Andersen NS, Nielsen OJ, Toft N, Schjødt I. Gjærde LK, et al. Among authors: friis ls. Leuk Lymphoma. 2022 Feb;63(2):416-425. doi: 10.1080/10428194.2021.1992620. Epub 2021 Oct 21. Leuk Lymphoma. 2022. PMID: 34672245
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease.
Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H. Nygaard M, et al. Among authors: friis ls. Bone Marrow Transplant. 2019 Jan;54(1):35-43. doi: 10.1038/s41409-018-0206-5. Epub 2018 May 8. Bone Marrow Transplant. 2019. PMID: 29740177 Clinical Trial.
59 results